RUNX3 (R3-5G4) Alexa Fluor® 488 Antibody sc-101553 AF488 from Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

(1) Increased RUNX3 expression mediates tumor-promoting ability of human breast cancer-associated fibroblastsCancer medicineSeptember 1, 2023Koyama Y, Okazaki H, Shi Y, Mezawa Y, Wang Z, Sakimoto M, Ishizuka A, Ito Y, Koyama T, Daigo Y, et al.

(2) CRISPR Activation Screening Identifies VGLL3-TEAD1-RUNX1/3 as a Transcriptional Complex for PD-L1 ExpressionJournal of immunology (Baltimore, Md. : 1950)September 1, 2022Wijdeven RH, Cabukusta B, Behr FM, Qiu X, Amiri D, Borras DM, Arens R, Liang Y, Neefjes J.

(3) Small peptide inhibitor from the sequence of RUNX3 disrupts PAK1-RUNX3 interaction and abrogates its phosphorylation-dependent oncogenic functionOncogeneAugust 1, 2021Kanumuri R, Chelluboyina AK, Biswal J, Vignesh R, Pandian J, Venu A, Vaishnavi B, Leena DJ, Jeyaraman J, Ganesan K, et al.

(4) RUNX1 gene expression changes in the placentas of women smokersExperimental and therapeutic medicineAugust 1, 2021Bermudez LG, Madariaga I, Zuñiga MI, Olaya M, Cañas A, Rodriguez LS, Moreno OM, Rojas A.

(5) Super-enhancers for RUNX3 are required for cell proliferation in EBV-infected B cell linesGeneMarch 30, 2021Hosoi H, Niibori-Nambu A, Nah GSS, Bahirvani AG, Mok MMH, Sanda T, Kumar AP, Tenen DG, Ito Y, Sonoki T, et al.

(6) A parallelized, automated platform enabling individual or sequential ChIP of histone marks and transcription factorsProceedings of the National Academy of Sciences of the United States of AmericaJune 16, 2020Dainese R, Gardeux V, Llimos G, Alpern D, Jiang JY, Meireles-Filho ACA, Deplancke B.

(7) Overexpression of RUNX3 Represses RUNX1 to Drive Transformation of Myelodysplastic SyndromeCancer researchJune 15, 2020Yokomizo-Nakano T, Kubota S, Bai J, Hamashima A, Morii M, Sun Y, Katagiri S, Iimori M, Kanai A, Tanaka D, et al.

(8) Brentuximab vedotin for refractory anaplastic lymphoma kinase-negative anaplastic large cell lymphoma in leukemic phase with RUNX3 overexpressionHematology reportsMay 6, 2020Yamashita Y, Hori Y, Kosako H, Oiwa T, Warigaya K, Mushino T, Murata S, Fujimoto M, Nishikawa A, Murata SI, et al.

(9) Threonine 209 phosphorylation on RUNX3 by Pak1 is a molecular switch for its dualistic functionsOncogeneSeptember 15, 2016Kumar A, Singhal M, Chopra C, Srinivasan S, Surabhi RP, Kanumuri R, Tentu S, Jagadeeshan S, Sundaram S, Ramanathan K, et al.

(10) RUNX super-enhancer control through the Notch pathway by Epstein-Barr virus transcription factors regulates B cell growthNucleic acids researchJune 2, 2016Gunnell A, Webb HM, Wood CD, McClellan MJ, Wichaidit B, Kempkes B, Jenner RG, Osborne C, Farrell PJ, West MJ.

(11) RUNX3 and CAMK2N1 hypermethylation as prognostic marker for epithelial ovarian cancerInternational journal of cancerJanuary 1, 2016Häfner N, Steinbach D, Jansen L, Diebolder H, Dürst M, Runnebaum IB.

(12) Runt-related transcription factor RUNX3 is a target of MDM2-mediated ubiquitinationCancer researchOctober 15, 2009Chi XZ, Kim J, Lee YH, Lee JW, Lee KS, Wee H, Kim WJ, Park WY, Oh BC, Stein GS, et al.

RUNX3 (R3-5G4) Alexa Fluor® 488 Antibody